Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Italy Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20041
20054
20078
20085
20094
20105
20115
20122
20134
201412
20154
20168
20176
20186
20199
20206
202113
20227
20235
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Terminated25
Active, not recruiting15
Recruiting15
Unknown status14
Withdrawn2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Celgene13
Gruppo Italiano Malattie EMatologiche dell'Adulto8
European Organisation for Research and Treatment of Cancer - EORTC6
Fondazione Italiana Sindromi Mielodisplastiche-ETS6
Bristol-Myers Squibb4
AbbVie3
Associazione Qol-one3
Bellicum Pharmaceuticals3
Taiho Oncology, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes131
Leukemia, Myeloid, Acute40
Leukemia, Myelomonocytic, Chronic20
Anemia17
Leukemia15
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Hematologic Neoplasms11
Anemia, Refractory, with Excess of Blasts10
Multiple Myeloma8
Myeloproliferative Disorders8

Trials

Showing 26 to 50 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.